JPS6429314A - Medicine dosage - Google Patents

Medicine dosage

Info

Publication number
JPS6429314A
JPS6429314A JP63162378A JP16237888A JPS6429314A JP S6429314 A JPS6429314 A JP S6429314A JP 63162378 A JP63162378 A JP 63162378A JP 16237888 A JP16237888 A JP 16237888A JP S6429314 A JPS6429314 A JP S6429314A
Authority
JP
Japan
Prior art keywords
estradiol
side effects
desogestrel
administration
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63162378A
Other languages
English (en)
Inventor
Yosefu Uiruherumu Ma Ranberuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of JPS6429314A publication Critical patent/JPS6429314A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
JP63162378A 1987-07-06 1988-06-29 Medicine dosage Pending JPS6429314A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8701586 1987-07-06

Publications (1)

Publication Number Publication Date
JPS6429314A true JPS6429314A (en) 1989-01-31

Family

ID=19850262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63162378A Pending JPS6429314A (en) 1987-07-06 1988-06-29 Medicine dosage

Country Status (12)

Country Link
US (1) US4914089A (ja)
EP (1) EP0300523B1 (ja)
JP (1) JPS6429314A (ja)
KR (1) KR950010156B1 (ja)
AT (1) ATE66149T1 (ja)
AU (1) AU611168B2 (ja)
CA (1) CA1313622C (ja)
DE (1) DE3864210D1 (ja)
DK (1) DK376188A (ja)
ES (1) ES2024010B3 (ja)
GR (1) GR3003104T3 (ja)
ZA (1) ZA884418B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04352795A (ja) * 1991-01-22 1992-12-07 Merck & Co Inc 新規な骨作用剤

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
IL113816A (en) 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical preparations containing desogestral, their preparation and use
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
MXPA05010871A (es) * 2003-04-11 2005-11-25 Barr Lab Inc Metodos para administrar estrogenos y progestinas.
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
USD731568S1 (en) * 2013-08-01 2015-06-09 Sejong Pharmatech Co., Ltd. Compression molding machine for tablets
USD741386S1 (en) * 2013-09-13 2015-10-20 Carefusion Germany 326 Gmbh Machine for packaging dosed quantities of solid drug portions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140914A (en) * 1980-03-18 1981-11-04 Akzo Nv Oral contraception multiphase combination type sequential preparation and oral contraception method
JPS60100520A (ja) * 1983-08-05 1985-06-04 プリ　ジエイ　ホールディングス　リミテッド 周閉経期、閉経期および閉経期後の障害をホルモン的に治療する医薬品組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (ja) * 1966-11-02 1968-05-03
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
GB8617560D0 (en) * 1986-07-18 1986-08-28 Raychem Gmbh Cable connector

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140914A (en) * 1980-03-18 1981-11-04 Akzo Nv Oral contraception multiphase combination type sequential preparation and oral contraception method
JPS60100520A (ja) * 1983-08-05 1985-06-04 プリ　ジエイ　ホールディングス　リミテッド 周閉経期、閉経期および閉経期後の障害をホルモン的に治療する医薬品組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04352795A (ja) * 1991-01-22 1992-12-07 Merck & Co Inc 新規な骨作用剤

Also Published As

Publication number Publication date
KR950010156B1 (en) 1995-09-11
KR890001564A (ko) 1989-03-27
GR3003104T3 (en) 1993-02-17
EP0300523B1 (en) 1991-08-14
AU611168B2 (en) 1991-06-06
CA1313622C (en) 1993-02-16
DK376188A (da) 1989-01-07
ES2024010B3 (es) 1992-02-16
ZA884418B (en) 1990-02-28
ATE66149T1 (de) 1991-08-15
DK376188D0 (da) 1988-07-06
EP0300523A1 (en) 1989-01-25
DE3864210D1 (de) 1991-09-19
US4914089A (en) 1990-04-03
AU1866888A (en) 1989-01-12

Similar Documents

Publication Publication Date Title
JPS6429314A (en) Medicine dosage
US4390531A (en) Method of contraception using peak progestogen dosage
DE3855606T2 (de) Verwendung von Melatonin zur Herstellung einer kontrazeptiven Zusammensetzung
DE3486442T2 (de) Verfahren zur hormonalen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
EP1898953B1 (en) Quadraphasic continuous graduated estrogen contraceptive
KR100221008B1 (ko) 프로게스토겐만을 함유하는 피임제
BG100940A (en) Combined hormonal contraception pharmaceutical preparation
JPH04290828A (ja) 低エストロゲン経口避妊薬
US3755575A (en) Pharmaceutical compositions
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
NZ307178A (en) Medicament for contraception; contains two, separately packed, sequential hormonal components
KR970706004A (ko) 호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies)
Fotherby Pharmacokinetics of ethynyloestradiol in humans
EP0235090B1 (en) Composition useful in the treatment of estrogen deficiencies
EP0322020A1 (en) Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
WO1994004156A1 (en) Antiprogestogen containing contraceptives
JPS5718617A (en) Antilipemic agent
Dionne et al. A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol
RU2000115313A (ru) Схемы приема гестаген-анти-гестагена
JPS5793913A (en) Enhancing agent for spermous vital power
Lebech Effects and side-effects of estrogen therapy
AU640112B2 (en) Estrogen and progestogen containing oral dosage forms
Manuilova et al. Lipid metabolism in hormonal contraception
Edgren Oral contraception: a review